1
|
Ray C, Kokkonen J, Simonsen N, Wackström N, Ray J, Engberg E. Parent-child nature visits and young Finnish childreńs nature connectedness. Eur J Public Health 2022. [PMCID: PMC9594851 DOI: 10.1093/eurpub/ckac131.336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Background It is well-known that frequent nature visits are associated with health benefits in children. Global climate crisis and environmental challenges emphasize the need for reconnecting children to nature, as well. Young children’s nature connectedness (NC) involves enjoyment of nature, sense of responsibility, empathy, and awareness of nature. The study examines whether there is an association between the frequency of parent-child nature visits and young children’s NC. Methods The study uses WEB survey data from the Finnish Empowered by Nature project. Respondents, n = 1463, were parents of children aged 2 to 7 years old. NC was assessed by 11-items derived from the NC questionnaire of Sobko et al (2018). Multinomial logistic regression analysis was used and the lowest tertile of NC was used as reference group. Analysis were adjusted for child’s age and gender, and highest education of parent. Results Children with moderate (1-2 times a week in previous month) or high (3 times a week or more) frequency of parent-child nature visits were more likely to have strong than weak NC compared to children with low frequency (less than once a week) of adult-child nature visits. Odds ratios (OR) in adjusted models were: moderate frequency 1.67 (1.21- 2.32), and high frequency 2.31 (1.67-3.18). The odds of having medium NC compared to weak NC were more likely in moderate frequency compared to low frequency of parent-child nature visits in the adjusted model (OR 1.46; 1.07-2.00). Conclusions The results highlight the importance of parents visiting nature frequently with their children during early childhood. It promotes young children’s NC and may further contribute to raising environmentally responsible children. Key messages • More frequent parent-child visits promote young children’s nature connectedness which involves enjoyment of nature, sense of responsibility, empathy, and awareness of nature. • A strong nature connectedness among children is highly relevant, as it may contribute to raise environmentally responsible children.
Collapse
Affiliation(s)
- C Ray
- Public Health, Folkhälsan Research Center , Helsinki, Finland
- Department of Food and Nutrition, University of Helsinki , Helsinki, Finland
| | - J Kokkonen
- Public Health, Folkhälsan Research Center , Helsinki, Finland
| | - N Simonsen
- Public Health, Folkhälsan Research Center , Helsinki, Finland
- Department of Public Health, University of Helsinki , Helsinki, Finland
| | - N Wackström
- Public Health, Folkhälsan Research Center , Helsinki, Finland
| | - J Ray
- Public Health, Folkhälsan Research Center , Helsinki, Finland
| | - E Engberg
- Public Health, Folkhälsan Research Center , Helsinki, Finland
- Department of Psychology and Logopedics, University of Helsinki , Helsinki, Finland
| |
Collapse
|
2
|
Simonsen N, Wackström N, Ray J. LärMiljö (Learning Environment) - study protocol: movement, outdoor learning and well-being in school. Eur J Public Health 2022. [PMCID: PMC9594400 DOI: 10.1093/eurpub/ckac131.337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Background Outdoor education (OE) is a teaching method aiming to promote children’s learning, physical activity (PA) and wellbeing. OE in green areas may further increase positive effects. There is little knowledge on use of OE and its possible effects in a Finnish context. Also, there is a need to evaluate OE from a teacher perspective. The aim of the LärMiljö-study is to: a) survey the use of OE in Swedish-language primary schools and investigate factors related to its use; b) investigate the associations between OE and PA, wellbeing, nature relations and learning among children aged 9-13 years, considering other related factors. Methods The self-determination theory (SDT) is used as theoretical framework. Data is collected via electronic surveys in Swedish-language primary schools, including: a) national surveys among principals and teachers; b) surveys among children and guardians. Children’s PA is measured for a 7-day period via accelerometers and a diary is kept. Teachers keep a class diary on OE provided. Academic tests are performed. Data will be analyzed using quantitative methods. Results This abstract describes the study protocol. The investigation of associations between OE and outcomes among children is mainly done by comparing classes that regularly use OE with classes that do not. Main outcomes are PA, psychosocial wellbeing, academic performance and nature connectedness; secondary outcomes are school motivation, social relations and sleep. Teachers’ experience and use of OE is explored, as is perceived effects of and barriers to OE use. Based on SDT, associations between OE and need satisfaction at work, competence, motivation and work engagement are studied. Conclusions The study represents a unique opportunity to explore OE use in primary schools, its effects among children and teachers, and what the supporting and hindering factors for its use are. The study contributes knowledge that can be used to promote learning and wellbeing in school. Key messages • Outdoor education in primary school may promote schoolchildren’s learning, physical activity, wellbeing and nature relation, but more knowledge is needed, including the perspective of teachers. • The LärMiljö-study will broaden the understanding of the potential effects of OE in primary education and school health promotion, and on factors supporting and hindering its use.
Collapse
Affiliation(s)
- N Simonsen
- Folkhälsan Research Center, Public Health Research Program , Helsinki, Finland
- University of Helsinki, Department of Public Health , Helsinki, Finland
| | - N Wackström
- Folkhälsan Research Center, Public Health Research Program , Helsinki, Finland
| | - J Ray
- Folkhälsan Research Center, Public Health Research Program , Helsinki, Finland
| |
Collapse
|
3
|
Stavrakas M, Smith R, Akil M, Kuet KP, Morley F, Ray J. Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vasculitis: One year's experience. Am J Otolaryngol 2022; 43:103485. [PMID: 35567837 DOI: 10.1016/j.amjoto.2022.103485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Accepted: 05/01/2022] [Indexed: 11/01/2022]
Abstract
PURPOSE ANCA-associated vasculitides (AAV) represent a group of diagnoses, including granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA). Most commonly, they present initially with ENT-associated symptomatology, and therefore they often pose a diagnostic challenge. We aim to present our one-year experience in the joint management of AAV in a multi-disciplinary setting. METHODS We performed a retrospective analysis based on the records of 39 patients who were seen in the joint clinic, during a period of one year. RESULTS After clinical assessment, 13 patients had changes made to their ENT treatment, 2 had some changes in their immunosuppression, while 11 had changes in both ENT and Rheumatology treatment. Six patients did not require any alterations to their therapeutic scheme. On average three separate appointments were reduced to a single appointment in the joint clinic where definitive treatment decisions were made. This led to significant cost reductions. CONCLUSIONS Cost-effectiveness, patient satisfaction, rapid multi-disciplinary evaluation, avoidance of unnecessary immunosuppression, patient education and medical training are only a few of the many advantages of this proposed joint service.
Collapse
|
4
|
Subbiah V, Gupta A, Ray J, Arora P, Thorlund K, Ramagopalan S. 1316P Comparative effectiveness of atezolizumab (Atz) versus docetaxel (Dtx) or nivolumab (Niv) in previously treated (pt) patients with advanced non-small cell lung cancer (aNSCLC): A US real-world (RW) study. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
5
|
McClymont E, Fell D, Albert A, Alton G, Barrett J, El-Chaar D, Harrold J, Krajden M, Lipsky N, Maan E, Malinowski A, Othman M, Raeside A, Ray J, Roberts A, Ryan G, Sadarangani M, Sauve L, van Schalkwyk J, Shah P, Snelgrove J, Sprague A, Ting J, Walker M, Whittle W, Williams C, Yudin M, Zipursky J, Abenhaim H, Boucoiran I, Castillo E, Crane J, Elwood C, Joynt C, Kotaska A, Martel J, Murphy-Kaulbeck L, Poliquin V, Ryan S, Saunders S, Scott H, Money D. Canadian surveillance of COVID-19 in pregnancy: Epidemiology and maternal and infant outcomes. Am J Obstet Gynecol 2020. [PMCID: PMC7683302 DOI: 10.1016/j.ajog.2020.08.137] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
6
|
Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C, Zhang Y, Borsuk R, Chang WI, Honeyman JN, Tavora F, Carneiro B, Raufi A, Huntington K, Carlsen L, Louie A, Safran H, Seyhan AA, Tarapore RS, Schalop L, Stogniew M, Allen JE, Oster W, El-Deiry WS. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia 2020; 22:725-744. [PMID: 33142238 PMCID: PMC7588802 DOI: 10.1016/j.neo.2020.09.005] [Citation(s) in RCA: 87] [Impact Index Per Article: 21.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Revised: 09/18/2020] [Accepted: 09/21/2020] [Indexed: 12/20/2022]
Abstract
ONC201 was originally discovered as TNF-Related Apoptosis Inducing Ligand (TRAIL)-inducing compound TIC10. ONC201 appears to act as a selective antagonist of the G protein coupled receptor (GPCR) dopamine receptor D2 (DRD2), and as an allosteric agonist of mitochondrial protease caseinolytic protease P (ClpP). Downstream of target engagement, ONC201 activates the ATF4/CHOP-mediated integrated stress response leading to TRAIL/Death Receptor 5 (DR5) activation, inhibits oxidative phosphorylation via c-myc, and inactivates Akt/ERK signaling in tumor cells. This typically results in DR5/TRAIL-mediated apoptosis of tumor cells; however, DR5/TRAIL-independent apoptosis, cell cycle arrest, or antiproliferative effects also occur. The effects of ONC201 extend beyond bulk tumor cells to include cancer stem cells, cancer associated fibroblasts and immune cells within the tumor microenvironment that can contribute to its efficacy. ONC201 is orally administered, crosses the intact blood brain barrier, and is under evaluation in clinical trials in patients with advanced solid tumors and hematological malignancies. ONC201 has single agent clinical activity in tumor types that are enriched for DRD2 and/or ClpP expression including specific subtypes of high-grade glioma, endometrial cancer, prostate cancer, mantle cell lymphoma, and adrenal tumors. Synergy with radiation, chemotherapy, targeted therapy and immune-checkpoint agents has been identified in preclinical models and is being evaluated in clinical trials. Structure-activity relationships based on the core pharmacophore of ONC201, termed the imipridone scaffold, revealed novel potent compounds that are being developed. Imipridones represent a novel approach to therapeutically target previously undruggable GPCRs, ClpP, and innate immune pathways in oncology.
Collapse
Key Words
- 5-fu, 5-fluorouracil
- a2a, adenosine 2a receptor
- alcl, anaplastic large cell lymphoma
- all, acute lymphoblastic leukemia
- aml, acute myeloid leukemia
- ampk, amp kinase
- atrt, atypical teratoid rhabdoid tumor
- auc, area under the curve
- brd, bromodomain
- camp, cyclic amp
- cck18, caspase-cleaved cytokeratin 18
- ck18, cytokeratin 18
- cll, chronic lymphocytic leukemia
- clpp, caseinolytic protease p
- clpx, caseinolytic mitochondrial matrix peptidase chaperone subunit x
- cml, chronic myelogenous leukemia
- crc, colorectal cancer
- csc, cancer stem cell
- ctcl, cutaneous t-cell lymphoma
- dipg, diffuse intrinsic pontine glioma
- dlbcl, diffuse large b-cell lymphoma
- dna-pkcs, dna-activated protein kinase catalytic subunit
- dr5, death receptor 5
- drd1, dopamine receptor d1
- drd2, dopamine receptor d2
- drd3, dopamine receptor d3
- drd4, dopamine receptor d4
- drd5, dopamine receptor d5
- dsrct, desmoplastic small round cell tumor
- ec, endometrial cancer
- egfr, epidermal growth factor receptor
- flair, fluid-attenuated inversion recovery
- gbm, glioblastoma multiforme
- gdsc, genomics of drug sensitivity in cancer
- girk, g protein-coupled inwardly rectifying potassium channel
- gnrh, gonadotropin-releasing hormone receptor
- gpcr, g protein coupled receptor
- hcc, hepatocellular carcinoma
- ihc, immunohistochemistry
- hgg, high-grade glioma
- isr, integrated stress response
- mcl, mantle cell lymphoma
- mm, multiple myeloma
- mtd, maximum tolerated dose
- nhl, non-hodgkin’s lymphoma
- nk, natural killer
- noael, no-observed-adverse-event-level
- nsclc, non-small cell lung cancer
- os, overall survival
- oxphos, oxidative phosphorylation
- pc-pg, pheochromocytoma-paraganglioma
- pd, pharmacodynamic
- pdx, patient-derived xenograft
- pfs, progression-free survival
- pk, pharmacokinetic
- plc, phospholipase c
- rano, response assessment in neuro-oncology
- recist, response evaluation criteria in solid tumors
- rhtrail, recombinant human trail
- rp2d, recommended phase ii dose
- sar, structure–activity relationship
- sclc, small-cell lung cancer
- tic10, trail-inducing compound 10
- tmz, temozolomide
- tnbc, triple-negative breast cancer
- trail, tnf-associated apoptosis-inducing ligand
- tunel, terminal deoxynucleotidyl transferase dutp nick end labeling
- who, world health organization
Collapse
Affiliation(s)
- Varun Vijay Prabhu
- Oncoceutics, Inc., 3675 Market St, Suite 200, Philadelphia, PA 19104, USA
| | - Sara Morrow
- Oncoceutics, Inc., 3675 Market St, Suite 200, Philadelphia, PA 19104, USA
| | | | - Lanlan Zhou
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Marie Ralff
- Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
| | - Jocelyn Ray
- Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
| | - Aakash Jhaveri
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Isacco Ferrarini
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Young Lee
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Cassandra Parker
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Yiqun Zhang
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Robyn Borsuk
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Wen-I Chang
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Joshua N Honeyman
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Fabio Tavora
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Benedito Carneiro
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Alexander Raufi
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Kelsey Huntington
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Lindsey Carlsen
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Anna Louie
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Howard Safran
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | - Attila A Seyhan
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA
| | | | - Lee Schalop
- Oncoceutics, Inc., 3675 Market St, Suite 200, Philadelphia, PA 19104, USA
| | - Martin Stogniew
- Oncoceutics, Inc., 3675 Market St, Suite 200, Philadelphia, PA 19104, USA
| | - Joshua E Allen
- Oncoceutics, Inc., 3675 Market St, Suite 200, Philadelphia, PA 19104, USA.
| | - Wolfgang Oster
- Oncoceutics, Inc., 3675 Market St, Suite 200, Philadelphia, PA 19104, USA
| | - Wafik S El-Deiry
- Warren Alpert Medical School, Brown University, 70 Ship Street, Room 537, Providence, RI 02912, USA.
| |
Collapse
|
7
|
Coughlin R, Della-Giustina D, Tsyrulnik A, Bod J, Brennan-Wydra E, Ray J, Duke J, Chandler I, Wong A, Goldflam K. 278 Identifying High Performer Residents in Emergency Medicine Training. Ann Emerg Med 2020. [DOI: 10.1016/j.annemergmed.2020.09.292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Curry N, Foley C, Wong H, Mora A, Curnow E, Zarankaite A, Hodge R, Hopkins V, Deary A, Ray J, Moss P, Reed MJ, Kellett S, Davenport R, Stanworth S. The application of a haemorrhage assessment tool in evaluating control of bleeding in a pilot trauma haemorrhage trial. Transfus Med 2019; 29:454-459. [PMID: 31680331 DOI: 10.1111/tme.12644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Revised: 08/22/2019] [Accepted: 10/06/2019] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To determine whether it was feasible to use a haemorrhage assessment tool (HAT) within a trauma trial and whether the data obtained could differentiate patients who had achieved haemostasis. BACKGROUND Major haemorrhage is one of the leading causes of death worldwide, affecting 40% of trauma patients. Clinical trials evaluating haemostatic interventions often use transfusion outcomes as a primary endpoint. Transfusion is highly dependent on local practice, limiting its reliability as a robust, transferable endpoint. METHODS A five-point HAT questionnaire was applied to participants enrolled into the EFIT-1 trial. This RCT evaluated the feasibility of administering a 6 g fibrinogen concentrate to patients with severe trauma haemorrhage. RESULTS Of participants, 98% completed a HAT; 75% participants had 'achieved haemostasis' at the time of tool completion, as determined by clinical acumen alone. HAT scores were able to differentiate which participants required transfusion after 3 h. Of participants, 56% were transfused red blood cells when they scored 0-2, compared to 17% with HAT scores between 3 and 5. CONCLUSION This study has confirmed the feasibility of using a HAT during the emergency care of patients suffering trauma haemorrhage, and future studies should be conducted to determine its value as an endpoint in haemostasis studies.
Collapse
Affiliation(s)
- N Curry
- Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, UK.,NIHR BRC Blood Theme, Oxford University, Oxford, UK
| | - C Foley
- NHS Blood and Transplant Clinical Trials Unit, NHS Blood and Transplant, Cambridge and Bristol, UK
| | - H Wong
- Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, UK.,NIHR BRC Blood Theme, Oxford University, Oxford, UK.,NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK
| | - A Mora
- NHS Blood and Transplant Clinical Trials Unit, NHS Blood and Transplant, Cambridge and Bristol, UK
| | - E Curnow
- NHS Blood and Transplant Clinical Trials Unit, NHS Blood and Transplant, Cambridge and Bristol, UK
| | - A Zarankaite
- NHS Blood and Transplant Clinical Trials Unit, NHS Blood and Transplant, Cambridge and Bristol, UK
| | - R Hodge
- NHS Blood and Transplant Clinical Trials Unit, NHS Blood and Transplant, Cambridge and Bristol, UK
| | - V Hopkins
- NHS Blood and Transplant Clinical Trials Unit, NHS Blood and Transplant, Cambridge and Bristol, UK
| | - A Deary
- NHS Blood and Transplant Clinical Trials Unit, NHS Blood and Transplant, Cambridge and Bristol, UK
| | - J Ray
- Department of Emergency Medicine, John Radcliffe Hospital, Oxford, UK
| | - P Moss
- Department of Emergency Medicine, St. George's Hospital, London, UK
| | - M J Reed
- Emergency Medicine Research Group Edinburgh (EMERGE), Royal Infirmary of Edinburgh, Edinburgh, UK
| | - S Kellett
- Department of Anaesthetics, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - R Davenport
- Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, UK
| | - S Stanworth
- Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, UK.,NIHR BRC Blood Theme, Oxford University, Oxford, UK.,NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK
| |
Collapse
|
9
|
Puts M, Strohschein F, Mclean B, Alqurini N, Syed A, Amir E, Béland F, Berger A, Bergman S, Vanderbyl B, Breunis H, Elser C, Emmenegger U, Fung S, Hsu T, Jang R, Krahn M, Koneru R, Kozlowski N, Krzyzanowska M, Lemonde M, Li A, Mariano C, Mehta R, Monette J, Papadakos J, Pitters E, Prica A, Ray J, Romanofsky L, Szumacher E, Wan-Chow-Wah D, Langleben A, Alibhai S. CLINICAL AND COST-EFFECTIVENESS OF COMPREHENSIVE GERIATRIC ASSESSMENT AND MANAGEMENT FOR CANADIAN ELDERS WITH CANCER: THE 5C STUDY – INITIAL RECRUITMENT AND IMPLEMENTATION RESULTS. J Geriatr Oncol 2019. [DOI: 10.1016/s1879-4068(19)31271-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Philpott CM, Smith R, Davies-Husband CR, Erskine S, Clark A, Welch A, Hopkins C, Carrie S, Ray J, Sunkaraneni V, Kara N, Kumar N, Robertson A, Anari S, Almeyda R, Wilson A. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study. Rhinology 2019; 57:303-312. [PMID: 31120456 DOI: 10.4193/rhin19.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
INTRODUCTION Pharmacological salicylates are known to trigger respiratory exacerbations in patients with Non-Steroidal Exacerbated Respiratory Disease (N-ERD), a specific phenotype of Chronic Rhinosinusitis (CRS) and asthma. The impact of dietary sources of salicylates across subgroups of CRS is not well understood. The hypothesis is that in patients with nasal polyps present, there is likely to be a higher incidence of symptom exacerbation due to dietary salicylates regardless of any known response to pharmacological salicylate. METHODS The Chronic Rhinosinusitis Epidemiology Study (CRES) was a questionnaire-based case-control study which sought to characterise the UK CRS population in terms of sociological, economic and medical factors. Using specific questions to examine participant responses relating to symptom exacerbation from food groups thought to be high in salicylate content, this analysis of the CRES database sought to compare an estimate of the prevalence of dietary sensitivity due to food with higher potential salicylate content across patients with CRS with (CRSwNPs) and without nasal polyposis (CRSsNPs) and with allergic fungal rhinosinusitis (AFRS). RESULTS The CRSwNPs group were significantly more likely than controls to report symptom exacerbation due to ingestion of food groups with higher potential dietary salicylate content. The same trend was observed amongst CRSsNPs participants to a lesser degree. Reported response to the individual specific food groups wine, nuts, spicy foods, fruit and vegetables demonstrated that a statistically significant proportion of CRSwNPs and AFRS participants reported sensitivity to wine. CONCLUSIONS This analysis suggests that there is an association between symptom exacerbation in response to food products with higher potential salicylate content, specifically wine, in CRS patients both with and without nasal polyposis when compared to controls, but especially in the CRSwNPs and AFRS phenotypes. Further studies are needed to detail if this relationship represents a causal relationship to dietary salicylate. The data present the possibility that a wider group of CRS patients may elicit salicylate sensitivity than those with known N-ERD.
Collapse
Affiliation(s)
- C M Philpott
- Norwich Medical School, University of East Anglia, Norfolk NR4 7TJ, United Kingdom; James Paget University Hospital NHS Foundation Trust, Gorleston, United Kingdom
| | - R Smith
- Norwich Medical School, University of East Anglia, Norfolk NR4 7TJ, United Kingdom; James Paget University Hospital NHS Foundation Trust, Gorleston, United Kingdom
| | | | - S Erskine
- Norwich Medical School, University of East Anglia, Norfolk NR4 7TJ, United Kingdom
| | - A Clark
- Norwich Medical School, University of East Anglia, Norfolk NR4 7TJ, United Kingdom
| | - A Welch
- Norwich Medical School, University of East Anglia, Norfolk NR4 7TJ, United Kingdom
| | - C Hopkins
- Guys and St Thomas Hospital, London, United Kingdom
| | - S Carrie
- Freeman Hospital, Newcastle, United Kingdom
| | - J Ray
- Sheffield University Teaching Hospitals, Sheffield, United Kingdom
| | - V Sunkaraneni
- Royal Surrey County Hospital, Guildford, United Kingdom
| | - N Kara
- Darlington Memorial Hospital, United Kingdom
| | - N Kumar
- Wrightington, Wigan and Leigh NHS Foundation Trust, United Kingdom
| | - A Robertson
- Southern General Hospital, Glasgow, United Kingdom
| | - S Anari
- Birmingham Heartlands Hospital, Birmingham, United Kingdom
| | - R Almeyda
- Royal Berkshire Hospital, Reading, United Kingdom
| | - A Wilson
- Norwich Medical School, University of East Anglia, Norfolk NR4 7TJ, United Kingdom
| |
Collapse
|
11
|
Ray J, Ralff M, Dicker D, El-Deiry W. Abstract 262: Anti-tumorigenic effect of ONC201 is enhanced by combination treatment with TRAIL or a DR5 agonist in endometrial cancer in vitro. Cancer Res 2019. [DOI: 10.1158/1538-7445.am2019-262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
ONC201 is a well-tolerated, orally active small molecule in the novel imipridone class that has anti-tumorigenic properties in a number of solid tumors, but not in non-neoplastic cells. ONC201 has demonstrated promising activity as a single agent in patients with advanced endometrial cancer in the first-in-human clinical trial with Phase II trials in endometrial cancer patients now underway. Although the mechanism of action in endometrial cell pathology has not been well studied, ONC201’s anti-tumor effect has been shown in other model systems to be p53-independent and mediated through activation of the integrated stress response (ISR) leading to DR5 activation and through induction of cell death or growth arrest. ONC201 inhibits ERK and AKT leading to upregulation of TRAIL in many systems. We hypothesized that ONC201 upregulation of DR5 could sensitize tumor cells to TRAIL and that TRAIL could convert growth arrest to cell death in ONC201-treated cells. Three endometrial cancer cell lines AN3CA, HEC1A and KLE were treated with ONC201 alone or in combination with TRAIL, or a DR5 agonist. Effects on cell viability were assessed by the Cell Titer-Glo cell viability assay, colony formation assays and cell cycle analysis by propidium iodide staining. QPCR and Western blot analysis were used to evaluate mRNA and protein expression, respectively. Assessment of TRAIL and DR5 cell surface expression was evaluated by surface staining using flow cytometry and FlowJo data analysis. ONC201 decreased the cell viability of all three endometrial cancer cell lines at clinically achievable low micro-molar concentrations. ONC201 activated the ISR and an anti-proliferative effect involving a G1 phase arrest and little cell death as indicated by increased Sub-G1 analysis and PARP cleavage. DR5 mRNA and protein expression at the cell surface were induced by ONC201. All three endometrial cancer cell lines were resistant to TRAIL alone, however, pre-treatment with ONC201 sensitized the AN3CA and KLE to TRAIL and a DR5 agonist, leading to potent cell death induction. The combination of ONC201 plus TRAIL did not cause appreciable cell death in normal human fibroblast. ONC201 decreases cell viability in endometrial cancer cells lines primarily through growth arrest while the combination of ONC201 and TRAIL or a DR5 agonist promotes cell death in AN3CA and KLE cells but not in HEC1A endometrial cancer cells. Our results suggest a novel cancer therapeutic strategy that can be exploited in the clinic.
Citation Format: Jocelyn Ray, Marie Ralff, David Dicker, Wafik El-Deiry. Anti-tumorigenic effect of ONC201 is enhanced by combination treatment with TRAIL or a DR5 agonist in endometrial cancer in vitro [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 262.
Collapse
|
12
|
Hoey C, Ahmed M, Fotouhi Ghiam A, Vesprini D, Huang X, Commisso K, Commisso A, Ray J, Fokas E, Loblaw DA, He HH, Liu SK. Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy. J Transl Med 2019; 17:173. [PMID: 31122242 PMCID: PMC6533745 DOI: 10.1186/s12967-019-1920-5] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2019] [Accepted: 05/15/2019] [Indexed: 01/12/2023] Open
Abstract
BACKGROUND Prostate cancer is an extremely heterogeneous disease. Despite being clinically similar, some tumours are more likely to recur after surgery compared to others. Distinguishing those that need adjuvant or salvage radiotherapy will improve patient outcomes. The goal of this study was to identify circulating microRNA that could independently predict prostate cancer patient risk stratification after radical prostatectomy. METHODS Seventy-eight prostate cancer patients were recruited at the Odette Cancer Centre in Sunnybrook Health Sciences Centre. All patients had previously undergone radical prostatectomy. Blood samples were collected simultaneously for PSA testing and miRNA analysis using NanoString nCounter technology. Of the 78 samples, 75 had acceptable miRNA quantity and quality. Patients were stratified into high- and low-risk categories based on Gleason score, pathological T stage, surgical margin status, and diagnostic PSA: patients with Gleason ≥ 8; pT3a and positive margin; pT3b and any margin; or diagnostic PSA > 20 µg/mL were classified as high-risk (n = 44) and all other patients were classified as low-risk (n = 31). RESULTS Using our patient dataset, we identified a four-miRNA signature (miR-17, miR-20a, miR-20b, miR-106a) that can distinguish high- and low-risk patients, in addition to their pathological tumour stage. High expression of these miRNAs is associated with shorter time to biochemical recurrence in the TCGA dataset. These miRNAs confer an aggressive phenotype upon overexpression in vitro. CONCLUSIONS This proof-of-principle report highlights the potential of circulating miRNAs to independently predict risk stratification of prostate cancer patients after radical prostatectomy.
Collapse
Affiliation(s)
- C Hoey
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
- Department of Medical Biophysics, University of Toronto, Toronto, Canada
| | - M Ahmed
- Princess Margaret Cancer Centre, niversity Health Network, Toronto, Canada
| | - A Fotouhi Ghiam
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
- Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, University of Toronto, Toronto, Canada
| | - D Vesprini
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
- Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, University of Toronto, Toronto, Canada
| | - X Huang
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
| | - K Commisso
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
| | - A Commisso
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
| | - J Ray
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
- Department of Medical Biophysics, University of Toronto, Toronto, Canada
| | - E Fokas
- Department of Radiotherapy and Oncology, Goethe-Universität Frankfurt am Main, Frankfurt, Germany
| | - D A Loblaw
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada
- Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, University of Toronto, Toronto, Canada
| | - H H He
- Department of Medical Biophysics, University of Toronto, Toronto, Canada
- Princess Margaret Cancer Centre, niversity Health Network, Toronto, Canada
| | - S K Liu
- Biological Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, Canada.
- Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, University of Toronto, Toronto, Canada.
| |
Collapse
|
13
|
Vigod S, Murphy K, Dennis C, Oberlander T, Ray J, Daskalakis Z, Blumberger D. Transcranial direct current stimulation (tDCS) for depression in pregnancy: a pilot randomized controlled trial. Brain Stimul 2019. [DOI: 10.1016/j.brs.2018.12.362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
14
|
Ganti AK, Ray J, Mooney KL, Zambrano E, Hillard PJA, Fok W. Unusual Cause of Pediatric Vaginal Bleeding: Infantile Capillary Hemangioma of the Cervix. J Pediatr Adolesc Gynecol 2019; 32:80-82. [PMID: 30107231 DOI: 10.1016/j.jpag.2018.08.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/26/2018] [Revised: 08/03/2018] [Accepted: 08/06/2018] [Indexed: 10/28/2022]
Abstract
BACKGROUND The differential diagnosis for pediatric prepubertal vaginal bleeding is wide. Rare etiologies include vascular malformations and tumors, such as infantile hemangiomas (IHs), which validate the usefulness of exam under anesthesia, vaginoscopy, and tissue diagnosis. CASE We report a case of an IH in a 6-year-old girl causing vaginal bleeding requiring transfusion. Vaginoscopy revealed a cervical IH of less than 1 cm. Expectant management and oral propranolol were successful management options. SUMMARY AND CONCLUSION Rare, even small soft tissue tumors such as IH can lead to impressive blood loss via vaginal bleeding. Accurate tissue diagnosis and a multidisciplinary approach are essential to planning safe, effective treatment, and follow-up.
Collapse
Affiliation(s)
- A K Ganti
- Department of Obstetrics and Gynecology, Stanford University, Stanford, California
| | - J Ray
- Department of Obstetrics and Gynecology, Stanford University, Stanford, California
| | - K L Mooney
- Department of Pathology, Stanford University, Stanford, California
| | - E Zambrano
- Department of Pathology, Stanford University, Stanford, California
| | - P J A Hillard
- Department of Obstetrics and Gynecology, Stanford University, Stanford, California.
| | - W Fok
- Department of Obstetrics and Gynecology, Stanford University, Stanford, California
| |
Collapse
|
15
|
Sandhu J, Yung M, Parker‐George J, Kearney B, Ray J. Assessment of vestibular function in patients with chronic middle ear disease using the
VHIT
and
VEMP
test. Clin Otolaryngol 2018; 43:1179-1182. [DOI: 10.1111/coa.13118] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/07/2018] [Indexed: 11/30/2022]
Affiliation(s)
- J.S. Sandhu
- Ear Nose and Throat Department Royal Hallamshire Hospital Sheffield UK
- Sheffield Institute for Translational Neuroscience University of Sheffield Sheffield UK
| | - M. Yung
- Ear Nose and Throat Department Ipswich Hospital Ipswich UK
| | | | - B. Kearney
- Department of Audiology Ipswich Hospital Ipswich UK
| | - J. Ray
- Ear Nose and Throat Department Royal Hallamshire Hospital Sheffield UK
| |
Collapse
|
16
|
Affiliation(s)
- J. Anderson
- Endodontics; US Air Force Postgraduate Dental School; Uniformed Services University; JBSA-Lackland TX USA
| | - J. Wealleans
- Endodontics; US Air Force Postgraduate Dental School; Uniformed Services University; JBSA-Lackland TX USA
| | - J. Ray
- Endodontics; US Air Force Postgraduate Dental School; Uniformed Services University; JBSA-Lackland TX USA
| |
Collapse
|
17
|
Acharya S, Ray J, Patro TU, Alegaonkar P, Datar S. Microwave absorption properties of reduced graphene oxide strontium hexaferrite/poly(methyl methacrylate) composites. Nanotechnology 2018; 29:115605. [PMID: 29336351 DOI: 10.1088/1361-6528/aaa805] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The key factors to consider when designing microwave absorber materials for eradication of electromagnetic (EM) pollution are absorption of incident EM waves and good impedance matching. By keeping these things in mind, flexible microwave absorber composite films can be fabricated by simple gel casting techniques using reduced graphene oxide (RGO) and strontium ferrite (SF) in a poly(methyl methacrylate) (PMMA) matrix. SF nanoparticles are synthesized by the well known sol-gel method. Subsequently, reduced graphene oxide (RGO) and SF nanocomposite (RGOSF) are prepared through a chemical reduction method using hydrazine. The structure, morphology, chemical composition, thermal stability and magnetic properties of the nanocomposite are characterized in detail by various techniques. The SF particles are found to be nearly 500 nm and decorated on RGO sheets as revealed by field emission scanning electron microscopy and transmission electron microscopy analysis. Fourier transform infrared and and Raman spectroscopy clearly show the presence of SF in the graphene sheet by the lower peak positions. Finally, ternary polymer composites of RGO/SF/PMMA are prepared by an in situ polymerization method. Magnetic and dielectric studies of the composite reveal that the presence of RGO/SF/PMMA lead to polarization effects contributing to dielectric loss. Also, RGO surrounding SF provides a conductive network in the polymer matrix which is in turn responsible for the magnetic loss in the composite. Thus, the permittivity as well as the permeability of the composite can be controlled by an appropriate combination of RGO and SF in PMMA. More than 99% absorption efficiency is achieved by a suitable combination of magneto-dielectric coupling in the X-band frequency range by incorporating 9 wt% of RGO and 1 wt% of SF in the polymer matrix.
Collapse
Affiliation(s)
- Sanghamitra Acharya
- Department of Applied Physics, Defence Institute of Advance Technology, Deemed University, Girinagar, Pune-411025, India
| | | | | | | | | |
Collapse
|
18
|
Orhan KS, Ray J, Polat B, Carr S, Enver N, Deleito JM, Greenwood L, Güldiken Y. Superiorly curved scalp incision for implantation of magnetic transcutaneous bone conduction devices: Multicentre experience of 60 patients. Clin Otolaryngol 2018; 43:949-952. [DOI: 10.1111/coa.13072] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/21/2018] [Indexed: 11/30/2022]
Affiliation(s)
- K. S. Orhan
- Istanbul Medical Faculty; Department of ORL; Istanbul University; Istanbul Turkey
| | - J. Ray
- Department of Otolaryngology; Sheffield Teaching Hospitals and Sheffield Children's NHS Trust; Sheffield UK
| | - B. Polat
- Istanbul Medical Faculty; Department of ORL; Istanbul University; Istanbul Turkey
| | - S. Carr
- Department of Otolaryngology; Sheffield Teaching Hospitals and Sheffield Children's NHS Trust; Sheffield UK
| | - N. Enver
- Istanbul Medical Faculty; Department of ORL; Istanbul University; Istanbul Turkey
| | - J. M. Deleito
- Department of Otolaryngology; Sheffield Teaching Hospitals and Sheffield Children's NHS Trust; Sheffield UK
| | - L. Greenwood
- Department of Otolaryngology; Sheffield Teaching Hospitals and Sheffield Children's NHS Trust; Sheffield UK
| | - Y. Güldiken
- Istanbul Medical Faculty; Department of ORL; Istanbul University; Istanbul Turkey
| |
Collapse
|
19
|
Marriott S, Hassiotis A, Ray J, Tyrer P. From inter-agency to multidisciplinary work in a sector generic mental health team. Psychiatr bull 2018. [DOI: 10.1192/pb.20.6.345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The effects of establishing a full multidisciplinary community psychiatric team in central London are described. The nature of referrals, and referrers' satisfaction with the service were examined during two comparable six-month periods, before and after the changes. The number and severity of referrals increased, and referrers were more satisfied with the new service. In contrast to the inter-agency model, the new multidisciplinary team was associated with more appropriate referral of those patients with the greatest need for specialist services. Clinical skill mix in the team and referrer education are the two factors most likely to have promoted these important changes. The key role of the psychiatrist in a full multidisciplinary team who can empower multi-professional case managers in their day-to-day management of severely ill patients is highlighted.
Collapse
|
20
|
Philpott C, Erskine S, Smith R, Hopkins C, Kara N, Farboud A, Salam M, Robertson A, Almeyda R, Kumar B, Anari S, Ray J, Cathcart R, Carrie S, Ahmed S, Khalil H, Clark A, Thomas M. Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES). Clin Otolaryngol 2017; 43:509-524. [DOI: 10.1111/coa.13012] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/12/2017] [Indexed: 11/29/2022]
Affiliation(s)
- C. Philpott
- James Paget University Hospital NHS Foundation Trust; Gorleston UK
- Norwich Medical School; University of East Anglia; Norfolk UK
| | - S. Erskine
- James Paget University Hospital NHS Foundation Trust; Gorleston UK
| | - R. Smith
- Norwich Medical School; University of East Anglia; Norfolk UK
| | - C. Hopkins
- Guys & St Thomas Hospital NHS Foundation Trust; London UK
| | - N. Kara
- County Durham & Darlington NHS Foundation Trust; Darlington UK
| | | | - M. Salam
- Ipswich Hospital NHS Foundation Trust; Ipswich UK
| | - A. Robertson
- Queen Elizabeth University Hospital Campus; Glasgow UK
| | - R. Almeyda
- Royal Berkshire NHS Foundation Trust; Reading UK
| | - B.N. Kumar
- Wrightington Wigan and Leigh NHS Foundation Trust; Wigan UK
| | - S. Anari
- Heart of England NHS Trust; Birmingham UK
| | - J. Ray
- Sheffield Teaching Hospitals NHSFT; Sheffield UK
| | | | | | - S. Ahmed
- University Hospitals Birmingham NHS Foundation Trust; Birmingham UK
| | | | - A. Clark
- Norwich Medical School; University of East Anglia; Norfolk UK
| | - M. Thomas
- Primary Care and population Sciences; University of Southampton; Southampton UK
| | | |
Collapse
|
21
|
Abstract
Higher surgical training in the UK faces a cut of two years. We conducted a questionnaire survey to assess the operative experience of current higher surgical trainees in otological surgery and the likely effect of the proposed reduction from six to four years. 91 (65%) of the 142 higher surgical trainees responded with details of major otological procedures performed (independently or assisting) over one year. In the present six-year scheme a typical trainee performs 72 myringoplasties, 79 mastoidectomies, 7 skull base procedures and 28 other procedures. In the first four years, however, his or her experience is only 39 myringoplasties, 44 mastoidectomies, 4 skull base procedures and 7 others. The large shortfall in experience that might result from shortening of the training programme would need to be met by intensification of the training or institution of accredited otology fellowships. Very similar dilemmas are faced by other surgical specialties.
Collapse
Affiliation(s)
- J Ray
- Department of Otolaryngology, University Hospital Birmingham, Edgbaston, Birmingham B15 2TH, UK.
| | | | | |
Collapse
|
22
|
Mead P, Hook S, Niesobecki S, Ray J, Meek J, Delorey M, Prue C, Hinckley A. Risk factors for tick exposure in suburban settings in the Northeastern United States. Ticks Tick Borne Dis 2017; 9:319-324. [PMID: 29174449 DOI: 10.1016/j.ttbdis.2017.11.006] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Revised: 06/24/2017] [Accepted: 11/09/2017] [Indexed: 11/29/2022]
Abstract
Prevention of tick-borne diseases requires an understanding of when and where exposure to ticks is most likely. We used an epidemiologic approach to define these parameters for residents of a Lyme-endemic region. Two persons in each of 500 Connecticut households were asked to complete a log each night for one week during June, 2013. Participants recorded their whereabouts in 15min increments (indoors, outdoors in their yard, outdoors on others' private property, or outdoors in public spaces) and noted each day whether they found a tick on themselves. Demographic and household information was also collected. Logs were completed for 934 participants in 471 households yielding 51,895 time-place observations. Median participant age was 49 years (range 2-91 years); 52% were female. Ninety-one participants (9.8%) reported finding a tick during the week, with slightly higher rates among females and minors. Household factors positively associated with finding a tick included having indoor/outdoor pets (odds ratio (OR)=1.7; 95% confidence interval (CI): 1.1-2.9), the presence of a bird feeder in the yard (OR=1.9; CI:1.2-3.2), and presence of an outdoor dining area (OR=2.2; CI:1.1-4.3). Individual factors associated with finding a tick on a given day were bathing or showering (OR=3.7; CI:1.3-10.3) and hours spent in one's own yard (OR=1.2, CI:1.1-1.3). Nineteen participants found ticks on multiple days, more than expected assuming independence (p<0.001). Participants who found ticks on multiple days did not spend more time outdoors but were significantly more likely to be male than those finding ticks on a single day (p<0.03). Our findings suggest that most tick exposures in the study area occurred on private property controlled by the respective homeowner. Interventions that target private yards are a logical focus for prevention efforts.
Collapse
Affiliation(s)
- P Mead
- Bacterial Diseases Branch, Division of Vector-borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
| | - S Hook
- Bacterial Diseases Branch, Division of Vector-borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
| | - S Niesobecki
- Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA
| | - J Ray
- Mayo Clinic, 200 First Street SW, Rochester, MN, USA
| | - J Meek
- Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA
| | - M Delorey
- Bacterial Diseases Branch, Division of Vector-borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
| | - C Prue
- Office of the Director, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - A Hinckley
- Bacterial Diseases Branch, Division of Vector-borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
| |
Collapse
|
23
|
Ray J, Chen Y, Bhat N, Bieber M, Teng N. Down Regulation of MAPK Signaling by Cytotoxic Human Monoclonal Antibody in Epithelial Ovarian Cancer. Gynecol Oncol 2017. [DOI: 10.1016/j.ygyno.2017.07.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
24
|
Ray J, Bhat N, Wender P, Teng N. Overcoming Clear Cell Ovarian Cancer Resistance to Taxol by an Oligo Arginine Transporter Conjugate. Gynecol Oncol 2017. [DOI: 10.1016/j.ygyno.2017.07.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Sehn L, Oestergaard M, Trněný M, Bosi A, Egyed M, Illes A, Nakamae H, Opat S, Topp M, Zaja F, Fingerle-Rowson G, Lei G, Nielsen T, Punnoose E, Rahman M, Ray J, Zhang L, Martelli M, Vitolo U. PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION IN UNTREATED DLBCL: RESULTS FROM THE PHASE III GOYA STUDY. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_121] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- L.H. Sehn
- Centre for Lymphoid Cancer; British Columbia Cancer Agency and the University of British Columbia; Vancouver Canada
| | - M.Z. Oestergaard
- Oncology Biomarker Development; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - M. Trněný
- Charles University; General Hospital; Prague Czech Republic
| | - A. Bosi
- Department of Hematology; Azienda Ospedaliero Universitaria Careggi; Florence Italy
| | - M. Egyed
- Department of Hematology; Kaposi Mor Teaching Hospital; Kaposvár Hungary
| | - A. Illes
- Department of Hematology; University of Debrecen, Faculty of Medicine; Debrecen Hungary
| | - H. Nakamae
- Department of Hematology; Osaka City University Hospital; Osaka Japan
| | - S. Opat
- Department of Clinical Haematology; Monash Health and Monash University; Melbourne Australia
| | - M. Topp
- Department of Haematology, Medizinische Klinik und Poliklinik II; Universitätsklinikum Würzburg; Würzburg Germany
| | - F. Zaja
- Department of Hematology, ASUIUD S. M. Misericordia; Udine Italy
| | - G. Fingerle-Rowson
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - G. Lei
- Department of Biostatistics, Roche Products Ltd; Welwyn Garden City UK
| | - T. Nielsen
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - E.A. Punnoose
- Oncology Biomarker Development; Genentech Inc.; South San Francisco USA
| | - M. Rahman
- Department of Biostatistics, Roche Products Ltd; Welwyn Garden City UK
| | - J. Ray
- Oncology Biomarker Development; Genentech Inc.; South San Francisco USA
| | - L. Zhang
- Department of Pathology; Ventana Medical Systems Inc.; Tucson USA
| | - M. Martelli
- Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy
| | - U. Vitolo
- Department of Hematology; Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino; Turin Italy
| |
Collapse
|
26
|
Carr S, Bruce I, Jones D, Ray J. Outcomes following conversion of a percutaneous to a transcutaneous bone conduction device in eight children. Clin Otolaryngol 2017; 42:917-920. [DOI: 10.1111/coa.12828] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/05/2017] [Indexed: 11/28/2022]
Affiliation(s)
- S.D. Carr
- Paediatric ENT Department; Sheffield Children's Hospital; Sheffield UK
| | - I.A. Bruce
- Paediatric ENT Department; Royal Manchester Children's Hospital; Central Manchester University Hospitals NHS Foundation Trust; Manchester Academic Health Science Centre; Manchester UK
- Respiratory and Allergy Centre; Institute of Inflammation and Repair; Faculty of Medical and Human Sciences; University of Manchester; Manchester UK
| | - D. Jones
- Paediatric Audiology Department; Royal Manchester Children's Hospital; Central Manchester University Hospitals NHS Foundation Trust; Manchester Academic Health Science Centre; Manchester UK
| | - J. Ray
- Paediatric ENT Department; Sheffield Children's Hospital; Sheffield UK
| |
Collapse
|
27
|
Saha B, Subramanian M, Gupta P, Patro BS, Ray J, Bandyopadhyay SK, Chattopadhyay S. trans-4,4'-Dihydroxystilbene (DHS) protects PC12 cells from oxidative damage but induces reactive oxygen species-mediated apoptosis in SHSY-5Y cell line. Indian J Exp Biol 2016; 54:719-728. [PMID: 30179393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Polyphenols can exert both, antioxidant and pro-oxidant properties, depending on cell types as well as their concentrations. Hence, it was of interest to examine if the naturally occurring resveratrol analog, trans-4,4'-dihydroxystilbene (DHS) also exert both these activities in a biphasic or cell-specific manner. In this study, we established the cytoprotective action of DHS against hydrogen peroxide (H2O2)-induced apoptotic death of the PC12 cells. DHS reduced mitochondrial membrane permeabilization and deactivated reactive oxygen species (ROS)-mediated caspase-3 activation in the H2O2-treated PC12 cells. However, it induced apoptosis in the human neuroblastoma SHSY-5Y cell line by destabilizing mitochondrial membrane, augmenting ROS and activating caspapse-3. DHS showed better activity than resveratrol in both the chosen models.
Collapse
|
28
|
Ghiam AF, Taeb S, Huang X, Jahangiri S, Ray J, Hoey C, Fokas E, Vesprini D, Bristow R, Boutros P, Liu S. The Biological Role and Clinical Significance of Long Noncoding RNA Urothelial Carcinoma Associated 1 (UCA1) in Prostate Cancer (PCa). Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
Sandhu JS, Manickavasagam J, Connolly D, Raghavan A, Fernando M, Ray J. Comparison of radiologically and histologically determined thickness of bone overlying the superior semicircular canal in sixty-six cadaveric specimens: impact on the diagnosis of Minor's Syndrome. Clin Otolaryngol 2016; 42:847-850. [PMID: 27385626 DOI: 10.1111/coa.12697] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/02/2016] [Indexed: 11/27/2022]
Affiliation(s)
- J S Sandhu
- Ear Nose and Throat Department, Sheffield Teaching Hospitals, Sheffield, UK
| | - J Manickavasagam
- Ear Nose and Throat Department, Sheffield Teaching Hospitals, Sheffield, UK
| | - D Connolly
- Department of Radiology, Sheffield Children's NHS Foundation, Sheffield, UK
| | - A Raghavan
- Department of Radiology, Sheffield Children's NHS Foundation, Sheffield, UK
| | - M Fernando
- Department of Histopathology, Sheffield Teaching Hospitals, Sheffield, UK
| | - J Ray
- Ear Nose and Throat Department, Sheffield Teaching Hospitals, Sheffield, UK
| |
Collapse
|
30
|
Erskine S, Hopkins C, Clark A, Anari S, Kumar N, Robertson A, Sunkaraneni S, Wilson J, Carrie S, Kara N, Ray J, Smith R, Philpott C. SNOT-22 in a control population. Clin Otolaryngol 2016; 42:81-85. [DOI: 10.1111/coa.12667] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/25/2016] [Indexed: 11/27/2022]
Affiliation(s)
- S.E. Erskine
- Norwich Medical School; University of East Anglia; Norwich UK
- ENT Department; James Paget University Hospital NHS Foundation Trust; Great Yarmouth UK
| | - C. Hopkins
- ENT Department; Guy's and St Thomas’ NHS Foundation Trust; London UK
| | - A. Clark
- Norwich Medical School; University of East Anglia; Norwich UK
| | - S. Anari
- ENT Department; Heart of England NHS Foundation Trust; Birmingham UK
| | - N. Kumar
- Otolaryngology, Head & Neck Surg; ENT Department; Writington, Wigan and Lee NHS Foundation Trust; Wigan UK
| | - A. Robertson
- ENT Department; Southern General Hospital; Glasgow UK
| | - S. Sunkaraneni
- ENT Department; Royal Surrey County Hospital; Guildford UK
| | - J.A. Wilson
- Otolaryngology, Head & Neck Surgery; Institute of Health & Society; Newcastle University; Newcastle upon Tyne UK
| | - S. Carrie
- ENT Department; Freeman Hospital; Newcastle upon Tyne UK
| | - N. Kara
- ENT Department; Royal Hallamshire Hospital; Sheffield UK
| | - J. Ray
- ENT Department; Darlington Memorial Hospitals NHS Foundation Trust; Darlington UK
| | - R. Smith
- Norwich Medical School; UEA; Norwich UK
| | - C.M. Philpott
- Norwich Medical School; University of East Anglia; Norwich UK
- ENT Department; James Paget University Hospital NHS Foundation Trust; Great Yarmouth UK
| | | |
Collapse
|
31
|
Waliszewski M, Nawaz F, Cicala C, Ray J, Olowojesiku R, Perrone I, Wei D, Jelicic K, Van Ryk D, Ansari AA, Fauci AS, Arthos J. Anti-α4β7 mAb prevents MAdCAM-1-mediated activation and HIV replication in CD4+ T cells. The Journal of Immunology 2016. [DOI: 10.4049/jimmunol.196.supp.208.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Abstract
HIV-1 preferentially infects α4β7+ CD4+ T cells, causing irreversible depletion of these cells in gut-associated lymphoid tissue (GALT) during the acute phase of infection. α4β7 mediates homing of CD4+ T cells to GALT through an interaction with mucosal addressin cell adhesion molecule-1 (MAdCAM-1), expressed on gut endothelial venules. In a rhesus macaque model of HIV transmission, administration of an anti-α4β7 mAb protected GALT from SIV infection. The mechanism(s) underlying this protection are poorly understood. We hypothesized that the anti-α4β7 mAb prevents MAdCAM mediated co-stimulation in a manner that could contribute to the protection that we observed. We determined that costimulation of CD4+ T cells through MAdCAM could support both proliferation of CD4+ T cells and viral replication in a manner that was inhibited by the anti-α4β7 mAb. In addition, MAdCAM costimulation induced the up-regulation of Ki-67, CD38 and CXCR5. Interestingly, we found that MAdCAM could induce the expression of CD45RO on naïve CD4+ T cells in the absence of proliferation, suggesting that this mode of costimulation is unique. These results indicate that costimulation of CD4+ T cells via MAdCAM provides a signal that promotes replication of HIV. Moreover, an anti-α4β7 mAb that interferes with the binding of MAdCAM to α4β7 inhibits both proliferation and viral replication, providing a potential mechanism for the capacity of this mAb to protect rhesus macaques from infection by SIV.
Collapse
|
32
|
Perrone I, Cicala C, Nawaz F, Ray J, Olowojesiku R, Waliszewski M, Jelicic K, Wei D, Van Ryk D, Ansari AA, Fauci AS, Arthos J. MAdCAM signaling through integrin α4β7 modulates surface expression of CCR5 and markers of CD4+ T cell activation. The Journal of Immunology 2016. [DOI: 10.4049/jimmunol.196.supp.207.13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Abstract
Integrin α4β7 mediates homing of lymphocytes, including CD4+ T cells, to gut-associated lymphoid tissue (GALT) through an interaction with Mucosal Addressin Cell Adhesion Molecule (MAdCAM), expressed on gut endothelial venules. MAdCAM facilitates rolling adhesion of CD4+ T lymphocytes along the gut endothelium prior to extravasation. Previous work also indicates that MAdCAM interactions with α4β7 provide a co-stimulatory signal to T cells. α4β7+/CD4+ T cells are a preferred target of HIV during the acute phase of infection. We hypothesized that signaling through α4β7 via MAdCAM renders cells susceptible to HIV infection and replication. In this study we characterized the response of α4β7+/CD4+ T cells to costimulation via MAdCAM in order to better understand whether the induced phenotype would support an enhanced degree of viral replication. We found that CD4+ T cells upregulated CCR5, an HIV coreceptor, in response to MAdCAM costimulation. We also observed the rapid induction of CD69, a known marker of activation. This induction was restricted to α4β7+ cells, including both the CD45RO+ α4β7+ memory subset and CD45ROneg/α4β7+ naive cell subset. We also observed decreased surface expression of two MAdCAM ligands; integrin β7+ was down-regulated within four hours post MAdCAM costimulation and L-selectin was shed with similar kinetics. This shedding occurred primarily in the CD45ROneg subset. Overall these results indicate that MAdCAM-mediated costimulation through α4β7 activates CD4+ T cells in a unique manner that is likely conducive to viral replication. Of note we found that CCR5, the principal HIV coreceptor, was upregulated. Interestingly, the surface expression of two MAdCAM ligands, L-selectin and α4β7, were both reduced.
Collapse
|
33
|
Ray J, Shin I, Ilgu M, Bendickson L, Gupta V, Kraus GA, Nilsen-Hamilton M. IMAGEtags: Quantifying mRNA Transcription in Real Time with Multiaptamer Reporters. Methods Enzymol 2016; 572:193-213. [PMID: 27241755 DOI: 10.1016/bs.mie.2016.02.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Cell communications are essential to the organization, development, and maintenance of multicellular organisms. Much of this communication involves changes in RNA transcription and is dynamic. Most methods for studying transcription require interrupting the continuity of cellular function by sacrificing the communicating cells and capturing gene expression information by periodic sampling of individual cells or the population. The IMAGEtag technology to quantify RNA levels in living cells, demonstrated here in yeast, allows individual cells to be tracked over time as they respond to different environmental cues. IMAGEtags are short RNAs consisting of strings of a variable number of tandem aptamers that bind small-molecule ligands. The aptamer strings can vary in length and in configuration of aptamer constituents, such as to contain multiples of the same aptamer or two or more different aptamers that alternate in their occurrence. A minimum effective length is about five aptamers. The maximum length is undefined. The small-molecule ligands are enabled for imaging as fluorophore conjugates. For each IMAGEtag, two fluorophore conjugates are provided, which are FRET pairs. When a cell expresses an RNA containing an IMAGEtag sequence, the aptamers bind their ligands and bring the fluorophores into sufficiently close proximity to allow FRET. The background fluorescence of both fluorophores is minimal in the FRET channel. These features endow IMAGEtags with the sensitivity to report on mRNA expression levels in living cells.
Collapse
Affiliation(s)
- J Ray
- Cornell University, Ithaca, NY, United States.
| | - I Shin
- National Forensic Service, Seoul, South Korea
| | - M Ilgu
- Aptalogic Inc., Ames, IA, United States
| | - L Bendickson
- Ames Laboratory, US DOE, Ames, IA, United States; Iowa State University, Ames, IA, United States
| | - V Gupta
- The Scripps Research Institute, Jupiter, FL, United States
| | - G A Kraus
- Ames Laboratory, US DOE, Ames, IA, United States; Iowa State University, Ames, IA, United States
| | - M Nilsen-Hamilton
- Ames Laboratory, US DOE, Ames, IA, United States; Iowa State University, Ames, IA, United States; Aptalogic Inc., Ames, IA, United States.
| |
Collapse
|
34
|
Ray J, Carr S, Popli G, Gibson W. An epidemiological study to investigate the relationship between Meniere's disease and migraine. Clin Otolaryngol 2016; 41:707-710. [DOI: 10.1111/coa.12608] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/29/2015] [Indexed: 01/03/2023]
Affiliation(s)
- J. Ray
- Deparment of Otolaryngology; Royal Hallamshire Hospital; Sheffield UK
| | - S.D. Carr
- Deparment of Otolaryngology; Royal Hallamshire Hospital; Sheffield UK
| | - G. Popli
- Deparment of Economics; University of Sheffield; Sheffield UK
| | - W.P. Gibson
- Sydney Cochlear Implant Centre; Gladesville Sydney NSW Australia
| |
Collapse
|
35
|
Xu J, Sivasubramaniyam T, Yinon Y, Tagliaferro A, Ray J, Nevo O, Post M, Caniggia I. Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia. Endocrinology 2016; 157:883-99. [PMID: 26653761 DOI: 10.1210/en.2015-1696] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
TGFβ has been implicated in preeclampsia, but its intracellular signaling via phosphorylated mothers against decapentaplegic (SMADs) and SMAD-independent proteins in the placenta remains elusive. Here we show that TGFβ receptor-regulated SMAD2 was activated (Ser(465/467) phosphorylation) in syncytiotrophoblast and proliferating extravillous trophoblast cells of first-trimester placenta, whereas inhibitory SMAD7 located primarily to cytotrophoblast cells. SMAD2 phosphorylation decreased with advancing gestation, whereas SMAD7 expression increased and shifted to syncytiotrophoblasts toward term. Additionally, we found that the TGFβ SMAD-independent signaling via partitioning defective protein 6 (PARD6)/Smad ubiquitylation regulatory factor was activated at approximately 10-12 weeks of gestation in cytotrophoblast and extravillous trophoblast cells comprising the anchoring column. Placentae from early-onset, but not late-onset, preeclampsia exhibited elevated SMAD2 phosphorylation and SMAD7 levels. Whereas PARD6 expression increased and SMURF1 levels decreased in preeclamptic placentae, their association increased. SMAD2 phosphorylation by TGFβ in villous explants and BeWo cells resulted in a reduction of Glial cell missing-1 (GCM1) and fusogenic protein syncytin-1 while increasing cell cycle regulators cyclin E-1 (CCNE1) and cyclin-dependent kinase 4. SMAD7 abrogated the proliferative effects of TGFβ. CCNE1 levels were increased in preeclamptic placentae, whereas GCM1 was markedly reduced. In addition, TGFβ treatment increased the association of PARD6 and SMURF1 and down-regulated Ras homolog gene family, member A (RHOA) GTPase in JEG3 cells. In a wound assay, TGFβ treatment increased the association of PARD6 and SMURF1 and triggered JEG3 cell migration through increased cellular protrusions. Taken together, our data indicate that TGFβ signaling via both SMAD2/7 and PARD6/SMURF1 pathways plays a role in trophoblast growth and differentiation. Altered SMAD regulation of GCM1 and CCNE1 and aberrant expression/activation of PARD6/SMURF1 may contribute to the pathogenesis of preeclampsia by affecting cellular pathways associated with this disorder.
Collapse
Affiliation(s)
- Jing Xu
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| | - Tharini Sivasubramaniyam
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| | - Yoav Yinon
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| | - Andrea Tagliaferro
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| | - Jocelyn Ray
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| | - Ori Nevo
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| | - Martin Post
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| | - Isabella Caniggia
- Lunenfeld-Tanenbaum Research Institute (J.X., T.S., A.T., J.R., I.C.), Mt Sinai Hospital, Toronto, Ontario, Canada M5T 3H7; Departments of Obstetrics and Gynecology (Y.Y., O.N., I.C.), Physiology (T.S., J.R., M.P., I.C.), and Pediatrics (M.P.), University of Toronto, Toronto, Ontario, Canada; and Institute of Medical Science (M.P.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| |
Collapse
|
36
|
Carr S, John R, Moraleda J, Ray J. Ultrasound to locate the bone-anchored hearing aid cover screw for placement of the abutment at bone-anchored hearing aid second stage. Clin Otolaryngol 2015; 40:295-6. [DOI: 10.1111/coa.12305] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/03/2014] [Indexed: 11/29/2022]
Affiliation(s)
- S. Carr
- Department of Otolaryngology; Sheffield Children's Hospital; Western Bank; Sheffield UK
| | - R. John
- Department of Anaesthesia; Sheffield Children's Hospital; Western Bank; Sheffield UK
| | - J. Moraleda
- Department of Otolaryngology; Sheffield Children's Hospital; Western Bank; Sheffield UK
| | - J. Ray
- Department of Otolaryngology; Sheffield Children's Hospital; Western Bank; Sheffield UK
| |
Collapse
|
37
|
Taniguchi Y, Takahashi Y, Toba T, Yamada S, Yokoi K, Kobayashi S, Okajima S, Shimane A, Kawai H, Yasaka Y, Smanio P, Oliveira MA, Machado L, Cestari P, Medeiros E, Fukuzawa S, Okino S, Ikeda A, Maekawa J, Ichikawa S, Kuroiwa N, Yamanaka K, Igarashi A, Inagaki M, Patel K, Mahan M, Ananthasubramaniam K, Mouden M, Yokota S, Ottervanger J, Knollema S, Timmer J, Jager P, Padron K, Peix A, Cabrera L, Pena Bofill V, Valera D, Rodriguez Nande L, Carrillo Hernandez R, Mena Esnard E, Fernandez Columbie Y, Bertella E, Baggiano A, Mushtaq S, Segurini C, Loguercio M, Conte E, Beltrama V, Petulla' M, Andreini D, Pontone G, Guzic Salobir B, Dolenc Novak M, Jug B, Kacjan B, Novak Z, Vrtovec M, Mushtaq S, Pontone G, Bertella E, Conte E, Segurini C, Volpato V, Baggiano A, Formenti A, Pepi M, Andreini D, Ajanovic R, Husic-Selimovic A, Zujovic-Ajanovic A, Mlynarski R, Mlynarska A, Golba K, Sosnowski M, Ameta D, Goyal M, Kumar D, Chandra S, Sethi R, Puri A, Dwivedi SK, Narain VS, Saran RK, Nekolla S, Rischpler C, Nicolosi S, Langwieser N, Dirschinger R, Laugwitz K, Schwaiger M, Goral JL, Napoli J, Forcada P, Zucchiatti N, Damico A, Damico A, Olivieri D, Lavorato M, Dubesarsky E, Montana O, Salgado C, Jimenez-Heffernan A, Ramos-Font C, Lopez-Martin J, Sanchez De Mora E, Lopez-Aguilar R, Manovel A, Martinez A, Rivera F, Soriano E, Maroz-Vadalazhskaya N, Trisvetova E, Vrublevskaya O, Abazid R, Kattea M, Saqqah H, Sayed S, Smettei O, Winther S, Svensson M, Birn H, Jorgensen H, Botker H, Ivarsen P, Bottcher M, Maaniitty T, Stenstrom I, Saraste A, Pikkarainen E, Uusitalo V, Ukkonen H, Kajander S, Bax J, Knuuti J, Choi T, Park H, Lee C, Lee J, Seo Y, Cho Y, Hwang E, Cho D, Sanchez Enrique C, Ferrera C, Olmos C, Jimenez - Ballve A, Perez - Castejon MJ, Fernandez C, Vivas D, Vilacosta I, Nagamachi S, Onizuka H, Nishii R, Mizutani Y, Kitamura K, Lo Presti M, Polizzi V, Pino P, Luzi G, Bellavia D, Fiorilli R, Madeo A, Malouf J, Buffa V, Musumeci F, Rosales S, Puente A, Zafrir N, Shochat T, Mats A, Solodky A, Kornowski R, Lorber A, Boemio A, Pellegrino T, Paolillo S, Piscopo V, Carotenuto R, Russo B, Pellegrino S, De Matteis G, Perrone-Filardi P, Cuocolo A, Piscopo V, Pellegrino T, Boemio A, Carotenuto R, Russo B, Pellegrino S, De Matteis G, Petretta M, Cuocolo A, Amirov N, Ibatullin M, Sadykov A A, Saifullina G, Ruano R, Diego Dominguez M, Rodriguez Gabella T, Diego Nieto A, Diaz Gonzalez L, Garcia-Talavera J, Sanchez Fernandez P, Leen A, Al Younis I, Zandbergen-Harlaar S, Verberne H, Gimelli A, Veltman C, Wolterbeek R, Bax J, Scholte A, Mooney D, Rosenblatt J, Dunn T, Vasaiwala S, Okuda K, Nakajima K, Nystrom K, Edenbrandt L, Matsuo S, Wakabayashi H, Hashimoto M, Kinuya S, Iric-Cupic V, Milanov S, Davidovic G, Zdravkovic V, Ashikaga K, Yoneyama K, Akashi Y, Shugushev Z, Maximkin D, Chepurnoy A, Volkova O, Baranovich V, Faibushevich A, El Tahlawi M, Elmurr A, Alzubaidi S, Sakrana A, Gouda M, El Tahlawi R, Sellem A, Melki S, Elajmi W, Hammami H, Okano M, Kato T, Kimura M, Funasako M, Nakane E, Miyamoto S, Izumi T, Haruna T, Inoko M, Massardo T, Swett E, Fernandez R, Vera V, Zhindon J, Fernandez R, Swett E, Vera V, Zhindon J, Alay R, Massardo T, Ohshima S, Nishio M, Kojima A, Tamai S, Kobayashi T, Murohara T, Burrell S, Van Rosendael A, Van Den Hoogen I, De Graaf M, Roelofs J, Kroft L, Bax J, Scholte A, Rjabceva I, Krumina G, Kalvelis A, Chanakhchyan F, Vakhromeeva M, Kankiya E, Koppes J, Knol R, Wondergem M, Van Der Ploeg T, Van Der Zant F, Lazarenko SV, Bruin VS, Pan XB, Declerck JM, Van Der Zant FM, Knol RJJ, Juarez-Orozco LE, Alexanderson E, Slart R, Tio R, Dierckx R, Zeebregts C, Boersma H, Hillege H, Martinez-Aguilar M, Jordan-Rios A, Christensen TE, Ahtarovski KA, Bang LE, Holmvang L, Soeholm H, Ghotbi AA, Andersson H, Ihlemann N, Kjaer A, Hasbak P, Gulya M, Lishmanov YB, Zavadovskii K, Lebedev D, Stahle M, Hellberg S, Liljenback H, Virta J, Metsala O, Yla-Herttuala S, Saukko P, Knuuti J, Saraste A, Roivainen A, Thackeray J, Wang Y, Bankstahl J, Wollert K, Bengel F, Saushkina Y, Evtushenko V, Minin S, Efimova I, Evtushenko A, Smishlyaev K, Lishmanov Y, Maslov L, Okuda K, Nakajima K, Kirihara Y, Sugino S, Matsuo S, Taki J, Hashimoto M, Kinuya S, Ahmadian A, Berman J, Govender P, Ruberg F, Miller E, Piriou N, Pallardy A, Valette F, Cahouch Z, Mathieu C, Warin-Fresse K, Gueffet J, Serfaty J, Trochu J, Kraeber-Bodere F, Van Dijk J, Mouden M, Ottervanger J, Van Dalen J, Jager P, Zafrir N, Ofrk H, Vaturi M, Shochat T, Hassid Y, Belzer D, Sagie A, Kornowski R, Kaminek M, Metelkova I, Budikova M, Koranda P, Henzlova L, Sovova E, Kincl V, Drozdova A, Jordan M, Shahid F, Teoh Y, Thamen R, Hara N, Onoguchi M, Hojyo O, Kawaguchi Y, Murai M, Udaka F, Matsuzawa Y, Bulugahapitiya DS, Avison M, Martin J, Liu YH, Wu J, Liu C, Sinusas A, Daou D, Sabbah R, Bouladhour H, Coaguila C, Aguade-Bruix S, Pizzi M, Romero-Farina G, Candell-Riera J, Castell-Conesa J, Patchett N, Sverdlov A, Miller E, Daou D, Sabbah R, Bouladhour H, Coaguila C, Smettei O, Abazid R, Boulaamayl El Fatemi S, Sallam L, Snipelisky D, Park J, Ray J, Shapiro B, Kostkiewicz M, Szot W, Holcman K, Lesniak-Sobelga A, Podolec P, Clerc O, Possner M, Liga R, Vontobel J, Mikulicic F, Graeni C, Benz D, Herzog B, Gaemperli O, Kaufmann P. Poster Session 1: Sunday 3 May 2015, 08:30-18:00 * Room: Poster Area. Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Nawaz F, Cicala C, Jelicic K, Cimbro R, Van Ryk D, Ray J, Hiatt J, Schwing C, Wei D, Pascuccio M, Ansari AA, Fauci AS, Arthos J. Functional Dynamics of the Interaction between HIV gp120 and α4β7. AIDS Res Hum Retroviruses 2014. [DOI: 10.1089/aid.2014.5079.abstract] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Fatima Nawaz
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | - Claudia Cicala
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | - Katija Jelicic
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | - Raffaello Cimbro
- Johns Hopkins University School of Medicine, Baltimore, MD, United States
| | - Donald Van Ryk
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | - Jocelyn Ray
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | - Joseph Hiatt
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | | | - Danlan Wei
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | | | - Aftab A. Ansari
- Emory University School of Medicine, Atlanta, MD, United States
| | - Anthony S. Fauci
- NIAID, National Institutes of Health, Bethesda, MD, United States
| | - James Arthos
- NIAID, National Institutes of Health, Bethesda, MD, United States
| |
Collapse
|
39
|
Cicala C, Jelicic K, Cimbro R, Nawaz F, Zheng X, Yang J, Lempicki R, Van Ryk D, Ray J, Hiatt J, Schwing C, Wei D, Pascuccio M, Kehrl J, Arthos J, Fauci AS. HIV-1 gp120 Impairs B Cell Proliferation by Inducing TGF-β1 Production and FcRL4 Expression. AIDS Res Hum Retroviruses 2014. [DOI: 10.1089/aid.2014.5449.abstract] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | | | | | | | - Xin Zheng
- NIH/NIAID, Laboratory of Immunopathogenesis and Bioinformatics, SAIC, Frederick, MD, United States
| | - Jun Yang
- NIH/NIAID, Laboratory of Immunopathogenesis and Bioinformatics, SAIC, Frederick, MD, United States
| | - Richard Lempicki
- NIH/NIAID, Laboratory of Immunopathogenesis and Bioinformatics, SAIC, Frederick, MD, United States
| | | | | | | | | | - Danlan Wei
- NIH/NIAID, LIR, Bethesda, MD, United States
| | | | - John Kehrl
- NIH/NIAID, LIR, Bethesda, MD, United States
| | | | | |
Collapse
|
40
|
Chakraborty S, Pramanik UD, Aumann T, Beceiro S, Boretzky K, Caesar C, Carlson B, Catford WN, Chatterjee S, Chartier M., Cortina-Gil D, Angelis G, Gonzalez-Diaz D, Emling H, Fernandez PD, Fraile LM, Ershova O, Geissel H, Heil M, Jonson B, Kelic A, Johansson H, Kruecken R, Kroll T, Kurcewicz J, Langer C, Bleis TL, Leifels Y, Munzenberg G, Marganiec J, Nociforo C, Najafi A, Panin V, Paschalis S, Pietri S, Plag R, Rahaman A, Reifarth R, Ricciardi V, Rossi D, Ray J, Simon H, Scheidenberger C, Typel S, Taylor J, Togano Y, Volkov V, Weick H, Wagner A, Wamers F, Weigand M, Winfield JS, Yakorev D, Zoric M. Ground-state configuration of neutron-rich Aluminum isotopes through Coulomb Breakup. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146602019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
41
|
Rahaman A, Datta Pramanik U, Aumann T, Beceiro S, Boretzky K, Caesar C, Carlson B, Catford W, Chakraborty S, Chatterjee S, Chartier M, Angelis G, Cortina-Gil D, Gonzalez-Diaz D, Emling H, Diaz Fernandez P, Fraile L, Ershova O, Geissel H, Heil M, Jonson B, Kelic A, Johansson H, Kruecken R, Kroll T, Kurcewicz J, Langer C, Bleis T, Leifels Y, Munzenberg G, Marganiec J, Nociforo C, Najafi A, Panin V, Paschalis S, Pietri S, Plag R, Reifarth R, Ricciardi V, Rossi D, Ray J, Simon H, Scheidenberge C, Typel S, Taylor J, Togano Y, Volkov V, Weick H, Wagner A, Wamers F, Weigand M, Winfield J, Yakorev D, Zoric M. Study of Ground State Wave-function of the Neutron-rich29,30Na Isotopes through Coulomb Breakup. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146602087] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Ray J, Datta Pramanik U, Bhowmik RK, Ray I, Rahaman A, Chakraborty A, Chakraborty S, Garg R, Goyal S, Ganguly S, Kumar S, Mandal S, Mukherjee B, Mukherjee P, Muralithar S, Negi D, Saxena M, Selvakumar K, Singh P, Singh AK, Singh RP. Exotic decay of hot rotating nuclei near proton drip line. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146602089] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Banerjee D, Hazra A, Seal T, Sur T, Bhattacharya D, Ray J, Mukherjee A, Mukherjee B. Antioxidant and Antiinflammatory Activities of Different Solvent Extracts and Isolated Compounds of Ipomoea pes-caprae (L) Sweet of Sunderban Mangrove Eco-complex. ACTA ACUST UNITED AC 2013. [DOI: 10.14233/ajchem.2013.14226] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
44
|
Allan K, Ray J, Gozdyra P, Kiss A, Morrison L, Buick J, Zhan C, Dorian P. 540 Variability in Potential Causal Factors Between “Cardiotoxic” Neighbourhoods With High Incidence of Out-of-Hospital Cardiac Arrest. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
45
|
Jaramillo DG, Haas B, De Mestral C, Sharma S, Hsiao M, Zagorski B, Rubenfeld G, Ray J, Nathens A. Sex-Associated Differences in Access to Trauma Center Care: A Population-Based Analysis. J Surg Res 2012. [DOI: 10.1016/j.jss.2011.11.415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
46
|
Aaltonen T, Alvarez González B, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Apresyan A, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barria P, Bartos P, Bauce M, Bauer G, Bedeschi F, Beecher D, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Binkley M, Bisello D, Bizjak I, Bland KR, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Brisuda A, Bromberg C, Brucken E, Bucciantonio M, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Calancha C, Camarda S, Campanelli M, Campbell M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cavalli-Sforza M, Cerri A, Cerrito L, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark A, Clarke C, Compostella G, Convery ME, Conway J, Corbo M, Cordelli M, Cox CA, Cox DJ, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Dagenhart D, d'Ascenzo N, Datta M, de Barbaro P, De Cecco S, De Lorenzo G, Dell'orso M, Deluca C, Demortier L, Deng J, Deninno M, Devoto F, d'Errico M, Di Canto A, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Dorigo M, Dorigo T, Ebina K, Elagin A, Eppig A, Erbacher R, Errede D, Errede S, Ershaidat N, Eusebi R, Fang HC, Farrington S, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Frank MJ, Franklin M, Freeman JC, Funakoshi Y, Furic I, Gallinaro M, Galyardt J, Garcia JE, Garfinkel AF, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Giannetti P, Gibson K, Ginsburg CM, Giokaris N, Giromini P, Giunta M, Giurgiu G, Glagolev V, Glenzinski D, Gold M, Goldin D, Goldschmidt N, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Grinstein S, Grosso-Pilcher C, Group RC, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn SR, Halkiadakis E, Hamaguchi A, Han JY, Happacher F, Hara K, Hare D, Hare M, Harr RF, Hatakeyama K, Hays C, Heck M, Heinrich J, Herndon M, Hewamanage S, Hidas D, Hocker A, Hopkins W, Horn D, Hou S, Hughes RE, Hurwitz M, Husemann U, Hussain N, Hussein M, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon EJ, Jha MK, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Junk TR, Kamon T, Karchin PE, Kasmi A, Kato Y, Ketchum W, Keung J, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim HW, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirby M, Klimenko S, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kreps M, Kroll J, Krop D, Krumnack N, Kruse M, Krutelyov V, Kuhr T, Kurata M, Kwang S, Laasanen AT, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lecompte T, Lee E, Lee HS, Lee JS, Lee SW, Leo S, Leone S, Lewis JD, Limosani A, Lin CJ, Linacre J, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu C, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maeshima K, Makhoul K, Malik S, Manca G, Manousakis-Katsikakis A, Margaroli F, Marino C, Martínez M, Martínez-Ballarín R, Mastrandrea P, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzione A, Mesropian C, Miao T, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Mondragon MN, Moon CS, Moore R, Morello MJ, Morlock J, Movilla Fernandez P, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norniella O, Nurse E, Oakes L, Oh SH, Oh YD, Oksuzian I, Okusawa T, Orava R, Ortolan L, Pagan Griso S, Pagliarone C, Palencia E, Papadimitriou V, Paramonov AA, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Poukhov O, Prokoshin F, Pronko A, Ptohos F, Pueschel E, Punzi G, Pursley J, Rahaman A, Ramakrishnan V, Ranjan N, Ray J, Redondo I, Renton P, Rescigno M, Riddick T, Rimondi F, Ristori L, Robson A, Rodrigo T, Rodriguez T, Rogers E, Rolli S, Roser R, Rossi M, Rubbo F, Ruffini F, Ruiz A, Russ J, Rusu V, Safonov A, Sakumoto WK, Sakurai Y, Santi L, Sartori L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt A, Schmidt EE, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sforza F, Sfyrla A, Shalhout SZ, Shears T, Shepard PF, Shimojima M, Shiraishi S, Shochet M, Shreyber I, Simonenko A, Sinervo P, Sissakian A, Sliwa K, Smith JR, Snider FD, Soha A, Somalwar S, Sorin V, Squillacioti P, Stancari M, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Strycker GL, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thome J, Thompson GA, Thomson E, Ttito-Guzmán P, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Tu Y, Ukegawa F, Uozumi S, Varganov A, Vázquez F, Velev G, Vellidis C, Vidal M, Vila I, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wagner RL, Wakisaka T, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Wilbur S, Wick F, Williams HH, Wilson JS, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe H, Wright T, Wu X, Wu Z, Yamamoto K, Yamaoka J, Yang T, Yang UK, Yang YC, Yao WM, Yeh GP, Yi K, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanetti A, Zeng Y, Zucchelli S. Search for a Higgs boson in the diphoton final state in pp collisions at sqrt[s]=1.96 TeV. Phys Rev Lett 2012; 108:011801. [PMID: 22304255 DOI: 10.1103/physrevlett.108.011801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/21/2011] [Indexed: 05/31/2023]
Abstract
A search for a narrow Higgs boson resonance in the diphoton mass spectrum is presented based on data corresponding to 7.0 fb{-1} of integrated luminosity from pp collisions at sqrt[s]=1.96 TeV collected by the CDF experiment. No evidence of such a resonance is observed, and upper limits are set on the cross section times branching ratio of the resonant state as a function of Higgs boson mass. The limits are interpreted in the context of the standard model and one fermiophobic benchmark model where the data exclude fermiophobic Higgs bosons with masses below 114 GeV/c{2} at a 95% Bayesian credibility level.
Collapse
Affiliation(s)
- T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki and Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Sankhla CS, Sankhe M, Ray J. 1.286 LONG TERM EFFICACY OF PALLIDAL DEEP BRAIN STIMULATION IN PATIENT WITH DYT 6 DYSTONIA FROM INDIA. Parkinsonism Relat Disord 2012. [DOI: 10.1016/s1353-8020(11)70344-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
48
|
McNamara S, Nuijten M, Summerhayes M, Ray J, Walzer S. 24 A cost-effectiveness analysis on the use of erlotinib (Tarceva) in the maintenance treatment of locally advanced or metastatic NSCLC patients with stable disease (SD) as best response to induction. Lung Cancer 2011. [DOI: 10.1016/s0169-5002(11)70024-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Ray J, Marzouk YM, Najm HN. A Bayesian approach for estimating bioterror attacks from patient data. Stat Med 2010; 30:101-26. [PMID: 20963771 DOI: 10.1002/sim.4090] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2007] [Accepted: 08/25/2010] [Indexed: 11/06/2022]
Abstract
Terrorist attacks using an aerosolized pathogen have gained credibility as a national security concern after the anthrax attacks of 2001. Inferring some important details of the attack quickly, for example, the number of people infected, the time of infection, and a representative dose received can be crucial to planning a medical response. We use a Bayesian approach, based on a short time series of diagnosed patients, to estimate a joint probability density for these parameters. We first test the formulation with idealized cases and then apply it to realistic scenarios, including the Sverdlovsk anthrax outbreak of 1979. We also use simulated outbreaks to explore the impact of model error, as when the model used for generating simulated epidemic curves does not match the model subsequently used to characterize the attack. We find that in all cases except for the smallest attacks (fewer than 100 infected people), 3-5 days of data are sufficient to characterize the outbreak to a specificity that is useful for directing an emergency response.
Collapse
Affiliation(s)
- J Ray
- Sandia National Laboratories, P.O. Box 969, Livermore, CA 94550-0969, USA.
| | | | | |
Collapse
|
50
|
van Dam T, Altamimi Z, Collilieux X, Ray J. Topographically induced height errors in predicted atmospheric loading effects. ACTA ACUST UNITED AC 2010. [DOI: 10.1029/2009jb006810] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|